Literature DB >> 7699066

Meningococcal infections in the Province of Québec, Canada, during the period 1991 to 1992.

L Ringuette1, M Lorange, A Ryan, F Ashton.   

Abstract

A total of 234 strains of Neisseria meningitidis obtained from hospitalized patients living in the province of Québec during the period 1991 to 1992 were characterized according to their serogroup, serotype, subtype, electrophoretic type, and antimicrobial susceptibility. All these strains were recovered from sterile body fluids, except for one strain that was isolated postmortem from a cutaneous lesion. For both years, serogroup C was the most prevalent (69.7%), followed by serogroup B (27.4%). Serotype 2a represented 80.3% of serogroup C isolates, and P1.2 was the most common subtype associated with this serotype. Clone ET 15 accounted for 76.5% of serogroup C isolates and 90.0% of serotype 2a strains. Although meningococcal disease occurred mostly in children under the age of 5 (9.7 cases per 100,000 children), with a peak incidence for children under 1 (20.3 cases per 100,000 children), most fatalities occurred among teenagers (12 to 19 years old). The total fatality rate was 11.5%, and serogroup C strains were responsible for 88.9% of these fatalities. Thirteen strains had a reduced susceptibility to penicillin G, and 28 strains were resistant to sulfadiazine. One strain was resistant to both rifampin and sulfadiazine and showed a reduced susceptibility to penicillin G.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7699066      PMCID: PMC227879          DOI: 10.1128/jcm.33.1.53-57.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

1.  Penicillin resistance in Neisseria meningitidis.

Authors:  G Riley; S Brown; C Krishnan
Journal:  N Engl J Med       Date:  1991-04-04       Impact factor: 91.245

Review 2.  Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics.

Authors:  R K Selander; D A Caugant; H Ochman; J M Musser; M N Gilmour; T S Whittam
Journal:  Appl Environ Microbiol       Date:  1986-05       Impact factor: 4.792

3.  Genetic diversity of penicillin G-resistant Neisseria meningitidis from Spain.

Authors:  P M Mendelman; D A Caugant; G Kalaitzoglou; E Wedege; D O Chaffin; J Campos; J A Saez-Nieto; M Viñas; R K Selander
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

4.  Meningococcal disease in Canada. Surveillance summary to 1987.

Authors:  P V Varughese; A O Carter
Journal:  Can Dis Wkly Rep       Date:  1989-04-29

5.  Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis.

Authors:  J Finne; M Leinonen; P H Mäkelä
Journal:  Lancet       Date:  1983-08-13       Impact factor: 79.321

6.  [gamma-Glutamyl-transferase activity in the family "Neisseriaceae" (author's transl)].

Authors:  J Y Riou; J Buissière; C Richard; M Guibourdenche
Journal:  Ann Microbiol (Paris)       Date:  1982 May-Jun

7.  Modified oxidation-fermentation medium for detection of acid production from carbohydrates by Neisseria spp. and Branhamella catarrhalis.

Authors:  J S Knapp; K K Holmes
Journal:  J Clin Microbiol       Date:  1983-07       Impact factor: 5.948

8.  Susceptibility-resistance pattern of Neisseria meningitidis isolated in the province of Ontario, Canada.

Authors:  R Shtibel
Journal:  Ann Microbiol (Paris)       Date:  1979-07

9.  Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children.

Authors:  R Gold; I Goldschneider; M L Lepow; T F Draper; M Randolph
Journal:  J Infect Dis       Date:  1978-02       Impact factor: 5.226

10.  NEISSERIA GONORRHOEAE. I. VIRULENCE GENETICALLY LINKED TO CLONAL VARIATION.

Authors:  D S KELLOGG; W L PEACOCK; W E DEACON; L BROWN; D I PIRKLE
Journal:  J Bacteriol       Date:  1963-06       Impact factor: 3.490

View more
  8 in total

1.  Sequence variation in the porA gene of a clone of Neisseria meningitidis during epidemic spread.

Authors:  J Jelfs; R Munro; E Wedege; D A Caugant
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

2.  Resolution of a meningococcal disease outbreak from whole-genome sequence data with rapid Web-based analysis methods.

Authors:  Keith A Jolley; Dorothea M C Hill; Holly B Bratcher; Odile B Harrison; Ian M Feavers; Julian Parkhill; Martin C J Maiden
Journal:  J Clin Microbiol       Date:  2012-07-11       Impact factor: 5.948

3.  Comparison of broth microdilution and E-test for susceptibility testing of Neisseria meningitidis.

Authors:  A Pascual; P Joyanes; L Martinez-Martinez; A I Suarez; E J Perea
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

4.  Invasive meningococcal disease in Quebec, Canada, due to an emerging clone of ST-269 serogroup B meningococci with serotype antigen 17 and serosubtype antigen P1.19 (B:17:P1.19).

Authors:  Dennis K S Law; Manon Lorange; Louise Ringuette; Réjean Dion; Michel Giguère; Averil M Henderson; Jan Stoltz; Wendell D Zollinger; Philippe De Wals; Raymond S W Tsang
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

Review 5.  Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Authors:  M van Deuren; P Brandtzaeg; J W van der Meer
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

6.  Waldenström's disease complicated by recurrent meningococcal arthritis.

Authors:  M Singwe-Ngandeu; N Buchs; P Rohner; C Gabay
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

7.  Invasive serogroup B Neisseria meningitidis in Quebec, Canada, 2003 to 2010: persistence of the ST-269 clone since it first emerged in 2003.

Authors:  Jianwei Zhou; Brigitte Lefebvre; Saul Deng; Rodica Gilca; Genevieve Deceuninck; Dennis K S Law; Philippe De Wals; Raymond S W Tsang
Journal:  J Clin Microbiol       Date:  2012-02-15       Impact factor: 5.948

8.  Phenotypic and genetic characterization of a unique variant of serogroup C ET-15 meningococci (with the antigenic formula C:2a:P1.7,1) causing invasive meningococcal disease in Quebec, Canada.

Authors:  Raymond S W Tsang; Chao Ming Tsai; Peixuan Zhu; Louise Ringuette; Manon Lorange; Dennis K S Law
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.